There’s nothing that medical technology companies can do about the Affordable Care Act or Sunshine Act. They’re here to stay.
That certainty is preferable to uncertainty because it allows companies to plan, according to an article on the Medical Device and Diagnostic Industry website.
At this point, the U.S. medical device industry “has a very clear idea of what the general outlines of the U.S. health care system are going to evolve toward for the next few years, writ large,” says Todd Evans of PricewaterhouseCoopers. “You have to take things for what they are and you have to respond to them intelligently and you need to begin taking real action.”